SRDX - SURMODICS INC

QQQ $ 439.97 $ 4.77 (1.1 %)

DIA $ 388.40 $ 1.68 (0.43 %)

SPY $ 516.34 $ 5.28 (1.03 %)

TLT $ 90.16 $ 0.35 (0.39 %)

GLD $ 215.21 $ 2.24 (1.05 %)

Previous Close

$ 32.48

Open

$ 32.23

Bid

$ 31.38 x 100

Ask

$ 0.00 x 0

Day's Range

$ 31.88 - $ 32.63

52 Week Range

$ 16.79 - $ 39.41

Volume

53,562

Average Volume

Market Cap

455.73M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-01-2024	03-31-2024	10-Q
2	02-01-2024	12-31-2023	10-Q
3	08-02-2023	06-30-2023	10-Q
4	04-26-2023	03-31-2023	10-Q
5	02-06-2023	12-31-2022	10-Q
6	11-23-2022	09-30-2022	10-K
7	07-27-2022	06-30-2022	10-Q
8	04-27-2022	03-31-2022	10-Q
9	02-04-2022	12-31-2021	10-Q
10	11-24-2021	09-30-2021	10-K
11	08-04-2021	06-30-2021	10-Q
12	04-28-2021	03-31-2021	10-Q
13	02-09-2021	12-31-2020	10-Q
14	12-02-2020	09-30-2020	10-K
15	08-05-2020	06-30-2020	10-Q
16	04-30-2020	03-31-2020	10-Q
17	02-07-2020	12-31-2019	10-Q
18	12-03-2019	09-30-2019	10-K
19	08-01-2019	06-30-2019	10-Q
20	05-03-2019	03-31-2019	10-Q
21	02-01-2019	12-31-2018	10-Q
22	11-30-2018	09-30-2018	10-K
23	08-06-2018	06-30-2018	10-Q
24	05-04-2018	03-31-2018	10-Q
25	02-08-2018	12-31-2017	10-Q
26	12-01-2017	09-30-2017	10-K
27	08-03-2017	06-30-2017	10-Q
28	04-28-2017	03-31-2017	10-Q
29	02-03-2017	12-31-2016	10-Q
30	12-02-2016	09-30-2016	10-K
31	07-29-2016	06-30-2016	10-Q
32	05-10-2016	03-31-2016	10-Q
33	02-05-2016	12-31-2015	10-Q
34	12-04-2015	09-30-2015	10-K
35	08-06-2015	06-30-2015	10-Q
36	05-05-2015	03-31-2015	10-Q
37	02-04-2015	12-31-2014	10-Q
38	12-05-2014	09-30-2014	10-K
39	08-01-2014	06-30-2014	10-Q
40	05-08-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Barrington Research Maintains Outperform o...
05/02/2024 18:26:11

Barrington Research analyst Michael Petusky maintains Surmodics (NASDAQ:SRDX) with a Outperform and maintains $71 price target.

Needham Maintains Buy on Surmodics, Lowers...
05/01/2024 18:28:58

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $47 to $43.

why-amd-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why AMD Shares Are Trading Lower By Around...
05/01/2024 17:01:56

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
05/01/2024 16:31:13

powell-industries-posts-upbeat-results-joins-a10-networks-garmin-dupont-and-other-big-stocks-moving-higher-on-wednesday

Powell Industries Posts Upbeat Results, Jo...
05/01/2024 14:27:48

Surmodics Sees FY24 Adj. EPS $(0.64)-$(0.4...
05/01/2024 11:05:07

Surmodics Q2 2024 Adj EPS $0.07 Beats $(0....
05/01/2024 11:01:33

Surmodics (NASDAQ:SRDX) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0.32) by ...

Needham Reiterates Buy on Surmodics, Maint...
04/10/2024 14:49:04

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:SRDX) with a Buy and maintains $47 price target.

Why C.H. Robinson Shares Are Trading Lower...
02/01/2024 18:17:44

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

Needham Maintains Buy on Surmodics, Raises...
02/01/2024 17:54:40

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and raises the price target from $44 to $47.

Surmodics Expects FY24 Adjusted EPS Loss O...
02/01/2024 12:15:48

Surmodics Expects FY24 Sales Of $117M-$121...
02/01/2024 12:13:01

Surmodics Q1 Adjusted EPS $0.00 May Not Be...
02/01/2024 12:02:29

Surmodics (NASDAQ:SRDX) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.30) by ...

Earnings Scheduled For February 1, 2024
02/01/2024 10:03:12

Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NY...

A Preview Of Surmodics's Earnings
01/31/2024 19:01:41

Surmodics Announced Early Clinical Use Of ...
01/22/2024 12:41:30

The Pounce LP Thrombectomy System, which received U.S. Food and Drug Administration (FDA) clearance in June 2023, is currently ...

Surmodics Announced 24-month Data From The...
11/16/2023 12:42:12

Surmodics Announced The presentation Of 36...
11/16/2023 12:31:37

Barrington Research Maintains Outperform o...
11/09/2023 16:42:14

Barrington Research analyst Michael Petusky maintains Surmodics (NASDAQ:SRDX) with a Outperform and raises the price target ...

Needham Maintains Buy on Surmodics, Lowers...
11/08/2023 22:10:25

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $50 to $44.